174 related articles for article (PubMed ID: 10960840)
1. Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer.
Bonkhoff H; Fixemer T; Hunsicker I; Remberger K
Prostate; 2000 Sep; 45(1):36-41. PubMed ID: 10960840
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor expression in human prostate cancer: correlation with tumor progression.
Bonkhoff H; Fixemer T; Hunsicker I; Remberger K
Prostate; 2001 Sep; 48(4):285-91. PubMed ID: 11536308
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
4. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
5. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
[TBL] [Abstract][Full Text] [Related]
6. Expression of ERalpha and ERbeta in prostate cancer.
Linja MJ; Savinainen KJ; Tammela TL; Isola JJ; Visakorpi T
Prostate; 2003 May; 55(3):180-6. PubMed ID: 12692783
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens.
Granchi S; Brocchi S; Bonaccorsi L; Baldi E; Vinci MC; Forti G; Serio M; Maggi M
Prostate; 2001 Dec; 49(4):267-77. PubMed ID: 11746273
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.
Rocchi P; So A; Kojima S; Signaevsky M; Beraldi E; Fazli L; Hurtado-Coll A; Yamanaka K; Gleave M
Cancer Res; 2004 Sep; 64(18):6595-602. PubMed ID: 15374973
[TBL] [Abstract][Full Text] [Related]
11. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
Zhigang Z; Wenlu S
Prostate; 2005 Dec; 65(4):299-305. PubMed ID: 16015594
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.
Bonkhoff H; Fixemer T; Hunsicker I; Remberger K
Am J Pathol; 1999 Aug; 155(2):641-7. PubMed ID: 10433957
[TBL] [Abstract][Full Text] [Related]
13. Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells.
Stope MB; Schubert T; Staar D; Rönnau C; Streitbörger A; Kroeger N; Kubisch C; Zimmermann U; Walther R; Burchardt M
World J Urol; 2012 Jun; 30(3):327-31. PubMed ID: 22362414
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of Hsp27 by ERα/Sp1 facilitates proliferation and confers resistance to apoptosis in human papillary thyroid cancer cells.
Mo XM; Li L; Zhu P; Dai YJ; Zhao TT; Liao LY; Chen GG; Liu ZM
Mol Cell Endocrinol; 2016 Aug; 431():71-87. PubMed ID: 27179757
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
[TBL] [Abstract][Full Text] [Related]
16. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
17. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
[TBL] [Abstract][Full Text] [Related]
18. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue.
Fasco MJ; Hurteau GJ; Spivack SD
Mol Cell Endocrinol; 2002 Feb; 188(1-2):125-40. PubMed ID: 11911952
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
20. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens.
Miller H; Poon S; Hibbert B; Rayner K; Chen YX; O'Brien ER
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):e10-4. PubMed ID: 15662019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
